CAFC Upholds Broad Institute CRISPR Patents

The Broad Institute of MIT and Harvard today withstood a closely-watched challenge to its CRISPR-Cas9 patents as the U.S. Court of Appeals for the Federal Circuit (CAFC) sided with the Broad over the University of California (UC), the University of Vienna, and Emmanuelle Charpentier, Ph.D., of the Helmholtz Centre for Infection Research in the bitter battle royal over who invented the gene-editing technology.The CAFC upheld a unanimous finding last year by a three-judge panel of the Patent Trial